Researchers are excited about the medication , a novel dual treatment showing promising outcomes in initial trials for body loss . It acts by targeting two systems: GLP-1 and GIP, these, when activated https://albiemkap216433.link4blogs.com/61626423/a-new-possibility-for-body-management